Drugs / Reiferon R
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02027493 Comparator | Feb 2009 → Jan 2011 | chronic hepatitis C virus infection | National Liver Institute, Egypt | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reiferon R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027493 ↗ |
| Modality | Protein / enzyme biologic | “Hansenula-derived PEGylated (polyethylene glycol) interferon (IFN)-alpha-2a (Reiferon Retard)” PMID 24782620 ↗ Apr 2014 |
| Route | Subcutaneous | “weekly subcutaneous injection of PEG-IFN-alpha-2a” PMID 24782620 ↗ Apr 2014 |